BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 33223089)

  • 21. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
    Odunukan OW; Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of paradoxical embolism (RoPE) study: initial description of the completed database.
    Thaler DE; Di Angelantonio E; Di Tullio MR; Donovan JS; Griffith J; Homma S; Jaigobin C; Mas JL; Mattle HP; Michel P; Mono ML; Nedeltchev K; Papetti F; Ruthazer R; Serena J; Weimar C; Elkind MS; Kent DM
    Int J Stroke; 2013 Dec; 8(8):612-9. PubMed ID: 22883936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of device closure of patent foramen ovale in patients with cryptogenic stroke.
    Fukutomi M; Wilkins B; Søndergaard L
    J Intern Med; 2020 Oct; 288(4):400-409. PubMed ID: 32812297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Patent Foramen Ovale in North Indian Cryptogenic Young Strokes.
    Khurana D; Petluri G; Kumar M; Bahl A; Kumar A; Gairolla J; Prabhakar S
    Neurol India; 2022; 70(3):1077-1082. PubMed ID: 35864642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke.
    Kent DM; Thaler DE;
    Trials; 2011 Jul; 12():185. PubMed ID: 21794121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke Prevention in Patients with Patent Foramen Ovale.
    Thaler A; Kvernland A; Kelly S; Song C; Aparicio HJ; Mac Grory B; Yaghi S
    Curr Cardiol Rep; 2021 Oct; 23(12):183. PubMed ID: 34718891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
    Turc G; Calvet D; Guérin P; Sroussi M; Chatellier G; Mas JL;
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
    Alushi B; Lauten A; Cassese S; Colleran R; Schüpke S; Rai H; Schunkert H; Meier B; Landmesser U; Kastrati A
    Clin Res Cardiol; 2018 Sep; 107(9):788-798. PubMed ID: 29644412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of closure of patent foramen ovale in cryptogenic stroke: Current status.
    Abhishek BS; Bhambhani A
    Natl Med J India; 2017; 30(5):268-271. PubMed ID: 29916427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closure of patent foramen ovale in cryptogenic stroke: a never ending story.
    Calvet D; Mas JL
    Curr Opin Neurol; 2014 Feb; 27(1):13-9. PubMed ID: 24300793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional prevention of paradoxical embolism as the gold standard: End of discussion?
    Nykl R; Precek J; Sluka M; Hudec S; Richter D; Heinc P; Taborsky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):241-248. PubMed ID: 34158673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.
    Lehmann R; Fichtlscherer S; Baldauf H; Schächinger V; Auch-Schwelck W; Zeiher AM; Teupe C
    J Cardiol; 2014 Aug; 64(2):113-6. PubMed ID: 24480741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.